-transparent.png){kind=logo}
Ninety-two outpatients with depressive disorders which met Research Diagnostic Criteria were treated either with mianserin or placebo in a 6-week controlled trial. Twenty-four of 42 (57%) mianserin-treated patients were rated responders to mianserin treatment while 15 of 50 (30%) were rated responders to placebo treatment (chi 2 = 6.89, p less than 0.01). This rate of drug response was comparable to that achieved with a tricyclic antidepressant in a similar study done in our clinic, supporting the use of mianserin in mildly depressed outpatients.
Related Publications
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
January 1994,
International clinical psychopharmacology,
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
January 1991,
Psychopharmacology bulletin,
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
September 1988,
Acta psychiatrica Scandinavica,
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
February 1992,
The Journal of clinical psychiatry,
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
August 1982,
Acta psychiatrica Scandinavica,
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
July 1972,
The Journal of clinical pharmacology and new drugs,
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
June 1995,
Journal of affective disorders,
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
April 1984,
The Journal of clinical psychiatry,
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
January 1990,
Psychopharmacology bulletin,
P J McGrath, and
J G Rabkin, and
J W Stewart, and
W Harrison, and
F M Quitkin, and
J Markowitz
January 1984,
Psychopharmacology,
